Literature DB >> 28614576

The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review.

Kiran Musunuru1,2.   

Abstract

Importance: Clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR-associated protein 9 (CRISPR-Cas9) has garnered a great degree of attention since its first reported uses in mammalian cells in early 2013 due to its perceived impact with respect to potential research applications and, especially, therapeutic applications. Observations: CRISPR-Cas9 is being widely used in the laboratory and has greatly improved the ability to generate genetically modified animal models of human diseases. First steps have been reported with respect to proof-of-concept cardiovascular therapeutic applications in mouse models-which might eventually lead to new treatments for patients-as well as modification of human embryos, which raises a host of social, ethical, and legal questions. Conclusions and Relevance: CRISPR-Cas9 is already having a substantial effect on cardiovascular basic science research. Although the first steps toward potential therapies have been taken, there are substantial obstacles that will need to be overcome if CRISPR-Cas9 is to be used in the practice of cardiovascular medicine.

Entities:  

Mesh:

Year:  2017        PMID: 28614576     DOI: 10.1001/jamacardio.2017.1713

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  13 in total

1.  The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature.

Authors:  Nienke de Graeff; Karin R Jongsma; Josephine Johnston; Sarah Hartley; Annelien L Bredenoord
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

2.  Editorial: Geriatrics in the 21st Century.

Authors:  B Vellas; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 3.  CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.

Authors:  Alexandra C Chadwick; Kiran Musunuru
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-24       Impact factor: 8.311

4.  CRISPR-Cas9 and He Jiankui's Case: an Islamic Bioethics Review using Maqasid al-Shari'a and Qawaid Fighiyyah.

Authors:  Nimah Alsomali; Ghaiath Hussein
Journal:  Asian Bioeth Rev       Date:  2021-03-20

Review 5.  The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.

Authors:  Benedetta M Motta; Peter P Pramstaller; Andrew A Hicks; Alessandra Rossini
Journal:  Stem Cells Int       Date:  2017-12-25       Impact factor: 5.443

Review 6.  Therapeutic genome editing in cardiovascular diseases.

Authors:  Masataka Nishiga; Lei S Qi; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2020-02-21       Impact factor: 15.470

7.  GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos.

Authors:  Erwei Zuo; Yidi Sun; Wu Wei; Tanglong Yuan; Wenqin Ying; Hao Sun; Liyun Yuan; Lars M Steinmetz; Yixue Li; Hui Yang
Journal:  Nat Protoc       Date:  2020-08-14       Impact factor: 13.491

Review 8.  Application of CRISPR/Cas9 Genome Editing Technology for the Improvement of Crops Cultivated in Tropical Climates: Recent Progress, Prospects, and Challenges.

Authors:  Effi Haque; Hiroaki Taniguchi; Md Mahmudul Hassan; Pankaj Bhowmik; M Rezaul Karim; Magdalena Śmiech; Kaijun Zhao; Mahfuzur Rahman; Tofazzal Islam
Journal:  Front Plant Sci       Date:  2018-05-08       Impact factor: 5.753

9.  In vivo CRISPR editing with no detectable genome-wide off-target mutations.

Authors:  Pinar Akcakaya; Maggie L Bobbin; Jimmy A Guo; Jose Malagon-Lopez; Kendell Clement; Sara P Garcia; Mick D Fellows; Michelle J Porritt; Mike A Firth; Alba Carreras; Tania Baccega; Frank Seeliger; Mikael Bjursell; Shengdar Q Tsai; Nhu T Nguyen; Roberto Nitsch; Lorenz M Mayr; Luca Pinello; Mohammad Bohlooly-Y; Martin J Aryee; Marcello Maresca; J Keith Joung
Journal:  Nature       Date:  2018-09-12       Impact factor: 49.962

Review 10.  Genotype-Based Recall Studies in Complex Cardiometabolic Traits.

Authors:  Paul W Franks; Nicholas J Timpson
Journal:  Circ Genom Precis Med       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.